Healthians is a diagnostics and wellness testing platform. The profitability of Healthians is a milestone reached after achieving breakeven in FY25. The company had impressive operations during the fiscal year ended on 31st March 2026. This is being propelled by the increasing need for home diagnostic testing and preventive health tests in its operating marketplaces.

Cost expenditure and revenue expansion

In FY26, Healthians’ topline expanded by 35.7% YoY to ₹357 crore compared with ₹263 crore in FY25. The Gurgaon-based firm offers home diagnostic facilities in over 250 cities and says it has now tested more than 10 crore people. 

In addition to its core operational activities, Healthians earned ₹5 crore in interest income during the year. This contributed additional interest income to the company, lifting the total interest income figure to ₹362 crore in FY26 from ₹270 crore during FY25. 

The company’s major business segment continues to be diagnostics, accounting for 99% of total operating revenues of the company, which reached ₹ 353 crore during the fiscal year. The rest of the income came from a small number of ancillary and supplemental services.

From the spending side, employee benefits were the highest expense category at Healthians, making up 36.8% of its total operational spend. In FY26, the company’s employee benefit expenditure increased by 28% on a year-on-year basis to ₹134 crore. The loss during testing and working operations on materials was ₹109 crore. 

Marketing expenses witnessed a decline, dropping to ₹44 crore during the same period. The combined amount of expenses, along with rent, legal, information technology infrastructure, and other general overheads, rose 32.4% from ₹275 crore in FY25 to ₹364 crore in FY26.

Financial performance and market landscape

Top-line revenue increased faster than total expenses, and indeed, Healthians realized a complete turnaround during the period. FY26 showed a net profit of ₹5.4 crore, an improvement from the net loss of ₹4.77 crore reported in FY25. Even after becoming profitable in FY26, the company has left a balance sheet accumulated with a history of losses standing at ₹976 crore. 

The unit economics of the firm indicate that in FY26, Healthians incurred a cost of ₹1.02 for generating operating revenues of every ₹1.00. The operating efficiency gains helped the company raise its earnings before interest, taxes, depreciation, and amortization margin to 2.20%, and ROCE was found to be at -4.86%. Healthians reported sound liquidity at the end of FY26, having recorded current assets of ₹112.5 crore.

Healthians had raised approximately $75 million in total equity capital for building infrastructure and expanding westward. Its main venture backers include several investment firms, including YouWeCan, DG Ventures, BEENEXT, and WestBridge. 

The company is based in key corporate functions and is also present in large metros, making it a direct competitor in the healthtech space to other players such as Orange Health, Redcliffe Labs, and Dr Lal PathLabs.

This is a financial turnaround and turn to profitability during a time of structural executive transition within the firm. In January 2026, following 10 years of building and scaling the enterprise, Deepak Sahni left all formal executive IOE duties.

Conclusion

The transition into profitability in FY26 is an important step that helps Healthians to balance fast growth and prudent management of its finances. This is due to an impressive increase in operating revenues by 35.7% to ₹357 crore, while managing its marketing expenditure, resulting in a profit of ₹5.4 crore.

With over 10 crore tests completed and a presence across 250 cities, backed by over $75 million in cumulative investor funding, Healthians has built a sustainable foundation. With its accumulated losses of ₹976 crore, the company’s positive EBITDA margin of 2.20% and solid asset base position will enable it to withstand future growth in the competitive Indian diagnostic market.